investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Targeting the p110beta isoform of PI3 kinase in prostate cancer
Thomas M Roberts
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Thomas M Roberts
Dana-Farber Cancer Institute
Boston, United States
Related projects
Martin Gleave
Targeting SEMA3C in Castration Resistant Prostate Cancer
Prostate
Pathology
Jayson Xiao Chen
Epigenetic changes in a PhIP-induced prostate cancer model in hCYP1A mice
Prostate
Carlo M Croce
MiRNAs/UCRs: Biomarkers for Cancer Risk, Tumor Detection, Progression and Treatment
Prostate
Massimo Loda
Molecular Link Between Metabolic Syndrome and Prostate Cancer
Prostate
Dipak Panigrahy
Controlling Cancer with Aspirin-Triggered Stimulation of Resolution
Prostate
Mark I Greene
Carbohydrate Antigenic Biomarkers for Epithelial Cancers
Prostate
Andrew Caleb Hsieh
Defining the role of eIF4F in metastatic castration resistant prostate cancer
Prostate
Steven P. Balk
SOX9 Mediation of AR and ERG Driven Prostate Cancer
Prostate
Matthew L Freedman
Defining the epigenetic landscape in human prostate cancer
Prostate
Pathology